2017 ATA guidelines on the management of thyroid dysfunctions in pregnancy: what do OB/GYNs need to know?

Research output: Contribution to journalReview article

Abstract

In the past two decades, the issue of thyroid dysfunctions during pregnancy and the postpartum period received increasing attention by both endocrinologists and obstetrics/gynecologists (OB/GYNs), the latter often became the first to diagnose an impaired thyroid function in pregnant women. In this setting, a series of different clinical guidelines have been published and reviewed, the latest ones being represented by the 2017 ATA guidelines, which extensively address a wide variety of topics, including iodine supplementation, thyroid autoimmunity, hyper- and hypo-thyroidism, thyroid nodules and cancer, post-partum management, as well as the need for pre-conception screening. Aim of this editorial is to offer a practical guidance to the OB/GYN reader by focusing upon evidence-based changes introduced by the latest guidelines, with particular regard to: (a) prescribing further endocrine testing before referral; (b) providing evidence-based answers to some of the frequently asked questions.

Original languageEnglish
Pages (from-to)276-279
Number of pages4
JournalGynecological Endocrinology
Volume35
Issue number4
DOIs
Publication statusPublished - Apr 3 2019

Fingerprint

Obstetrics
Thyroid Gland
Guidelines
Pregnancy
Thyroid Nodule
Autoimmunity
Thyroid Neoplasms
Iodine
Postpartum Period
Pregnant Women
Referral and Consultation
Endocrinologists

Keywords

  • guidelines
  • hypothyroidism
  • pregnancy
  • screening
  • Thyroid

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Obstetrics and Gynaecology

Cite this

2017 ATA guidelines on the management of thyroid dysfunctions in pregnancy : what do OB/GYNs need to know? / Rotondi, Mario; Capelli, Valentina; Chiovato, Luca; Nappi, Rossella E.

In: Gynecological Endocrinology, Vol. 35, No. 4, 03.04.2019, p. 276-279.

Research output: Contribution to journalReview article

@article{e0f481d3ef854a57b961de97dfe4c50d,
title = "2017 ATA guidelines on the management of thyroid dysfunctions in pregnancy: what do OB/GYNs need to know?",
abstract = "In the past two decades, the issue of thyroid dysfunctions during pregnancy and the postpartum period received increasing attention by both endocrinologists and obstetrics/gynecologists (OB/GYNs), the latter often became the first to diagnose an impaired thyroid function in pregnant women. In this setting, a series of different clinical guidelines have been published and reviewed, the latest ones being represented by the 2017 ATA guidelines, which extensively address a wide variety of topics, including iodine supplementation, thyroid autoimmunity, hyper- and hypo-thyroidism, thyroid nodules and cancer, post-partum management, as well as the need for pre-conception screening. Aim of this editorial is to offer a practical guidance to the OB/GYN reader by focusing upon evidence-based changes introduced by the latest guidelines, with particular regard to: (a) prescribing further endocrine testing before referral; (b) providing evidence-based answers to some of the frequently asked questions.",
keywords = "guidelines, hypothyroidism, pregnancy, screening, Thyroid",
author = "Mario Rotondi and Valentina Capelli and Luca Chiovato and Nappi, {Rossella E.}",
year = "2019",
month = "4",
day = "3",
doi = "10.1080/09513590.2018.1532496",
language = "English",
volume = "35",
pages = "276--279",
journal = "Gynecological Endocrinology",
issn = "0951-3590",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - 2017 ATA guidelines on the management of thyroid dysfunctions in pregnancy

T2 - what do OB/GYNs need to know?

AU - Rotondi, Mario

AU - Capelli, Valentina

AU - Chiovato, Luca

AU - Nappi, Rossella E.

PY - 2019/4/3

Y1 - 2019/4/3

N2 - In the past two decades, the issue of thyroid dysfunctions during pregnancy and the postpartum period received increasing attention by both endocrinologists and obstetrics/gynecologists (OB/GYNs), the latter often became the first to diagnose an impaired thyroid function in pregnant women. In this setting, a series of different clinical guidelines have been published and reviewed, the latest ones being represented by the 2017 ATA guidelines, which extensively address a wide variety of topics, including iodine supplementation, thyroid autoimmunity, hyper- and hypo-thyroidism, thyroid nodules and cancer, post-partum management, as well as the need for pre-conception screening. Aim of this editorial is to offer a practical guidance to the OB/GYN reader by focusing upon evidence-based changes introduced by the latest guidelines, with particular regard to: (a) prescribing further endocrine testing before referral; (b) providing evidence-based answers to some of the frequently asked questions.

AB - In the past two decades, the issue of thyroid dysfunctions during pregnancy and the postpartum period received increasing attention by both endocrinologists and obstetrics/gynecologists (OB/GYNs), the latter often became the first to diagnose an impaired thyroid function in pregnant women. In this setting, a series of different clinical guidelines have been published and reviewed, the latest ones being represented by the 2017 ATA guidelines, which extensively address a wide variety of topics, including iodine supplementation, thyroid autoimmunity, hyper- and hypo-thyroidism, thyroid nodules and cancer, post-partum management, as well as the need for pre-conception screening. Aim of this editorial is to offer a practical guidance to the OB/GYN reader by focusing upon evidence-based changes introduced by the latest guidelines, with particular regard to: (a) prescribing further endocrine testing before referral; (b) providing evidence-based answers to some of the frequently asked questions.

KW - guidelines

KW - hypothyroidism

KW - pregnancy

KW - screening

KW - Thyroid

UR - http://www.scopus.com/inward/record.url?scp=85064713364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064713364&partnerID=8YFLogxK

U2 - 10.1080/09513590.2018.1532496

DO - 10.1080/09513590.2018.1532496

M3 - Review article

C2 - 30721102

AN - SCOPUS:85064713364

VL - 35

SP - 276

EP - 279

JO - Gynecological Endocrinology

JF - Gynecological Endocrinology

SN - 0951-3590

IS - 4

ER -